Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neogenomics Inc
(NQ:
NEO
)
14.88
-0.20 (-1.33%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neogenomics Inc
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors
December 08, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against NeoGenomics, Inc. (NEO)
December 07, 2022
From
Robbins LLP
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NEO
December 07, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
NeoGenomics Announces Chief Financial Officer Transition
December 05, 2022
Via
ACCESSWIRE
Why Shares of NeoGenomics Jumped 53.9% This Week
November 11, 2022
The cancer screening company showed its turnaround may be working.
Via
The Motley Fool
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors
December 07, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of NeoGenomics, Inc. (NEO) Investors
December 07, 2022
From
Kirby McInerney LLP
Via
Business Wire
INVESTOR ALERT: NeoGenomics, Inc. Investors with Substantial Losses Have Opportunity to Lead the NeoGenomics Class Action Lawsuit - NEO
December 07, 2022
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Where NeoGenomics Stands With Analysts
November 09, 2022
Within the last quarter, NeoGenomics (NASDAQ:NEO) has observed the following analyst ratings:
Via
Benzinga
NeoGenomics Reports Third Quarter 2022 Results
November 08, 2022
Via
ACCESSWIRE
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in NeoGenomics, Inc. with Losses of $100,000 to Contact the Firm
December 07, 2022
From
The Schall Law Firm
Via
Business Wire
CORRECTING and REPLACING NEOGENOMICS INVESTOR ALERT: Gibbs Law Group Files Class Action Lawsuit on Behalf of NEO Investors
December 06, 2022
From
Gibbs Law Group
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Files Class Action on Behalf of Investors in NeoGenomics, Inc. and Advises Shareholders with Losses of $100,000 to Contact the Firm
December 06, 2022
From
The Schall Law Firm
Via
Business Wire
NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2022
Via
ACCESSWIRE
Big Developments Set to be Unveiled at This Year’s San Antonio Breast Cancer Symposium (SABCS)
November 30, 2022
EQNX::TICKER_START (NASDAQ:ONCY),(NYSE:LLY),(NASDAQ:NEO),(NYSE:ZYME),(NASDAQ:GTHX) EQNX::TICKER_END
Via
FinancialNewsMedia
RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease
November 21, 2022
Via
ACCESSWIRE
NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE(TM)
November 18, 2022
Via
ACCESSWIRE
BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday
November 17, 2022
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81%
November 11, 2022
Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to...
Via
Benzinga
Earnings Scheduled For November 11, 2022
November 11, 2022
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is expected to report quarterly loss at $0.37 per share on revenue of $919.90 million.
Via
Benzinga
DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday
November 09, 2022
U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday
November 09, 2022
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 08, 2022
Gainers
Via
Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
November 08, 2022
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast...
Via
Benzinga
NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors
November 07, 2022
Via
ACCESSWIRE
If You Invested $1,000 In These 3 Crypto Tokens You Would Have This Much In Crypto Dividends
October 28, 2022
When navigating the cryptocurrency market it can be difficult to distinguish between the “s— tokens” and tokens that actually provide value through a utility.
Via
Benzinga
NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch
October 28, 2022
Via
ACCESSWIRE
Aaron's, Celestica, Medpace Holdings And Some Other Big Stocks Moving Higher On Tuesday
October 25, 2022
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
October 26, 2022
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.
Via
Benzinga
Starbucks Plunges As Xi Jinping Consolidates Power: Here's What's Going On
October 24, 2022
Starbucks Corporation (NASDAQ: SBUX) was sliding about 6% lower on Monday in tandem with a number of China-based stocks.
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.